Trial Profile
Clinical study of combinational therapy of AD-4833 with metformin -Phase III double-blind comparative study-
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Takeda
- 01 May 2009 Primary endpoint 'Proportion of glycosylated haemoglobin' has been met.
- 08 May 2008 New trial record.